2226 results
ANCA Vasculitis - GPA, MPA, Eosinophilic GPA

doi:10.1038/s41572-020-0204-y

#ANCA #Vasculitis #GPA #MPA #Eosinophilic #rheumatology #diagnosis #comparison #table
ANCA Vasculitis - GPA ... , MPA, Eosinophilic ... GPA doi:10.1038 ... #MPA #Eosinophilic ... diagnosis #comparison #table
Rapidly Progressive Glomerulonephritis (RPGN)
RPGN has three primary pathophysiologic causes differentiated by immunofluorescence

Immune Complex Mediated (granular staining):
ANCA (C-ANCA): GPA ... >>> MPA > eGPA ... • MPO-ANCA (P-ANCA ... ): eGPA, MPA >>> ... GPA Stanford Internal
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
Polyangiitis (GPA ... Polyangiitis (MPA ... #Polyangiitis #GPA ... #Polyangiitis #MPA
ANCA-Associated Vasculitis
A group of necrotizing, small-vessel vasculitis without immune complex deposition. Complement levels are normal due
polyangiitis (GPA ... polyangiitis (MPA ... associated with MPO ... polyangiitis - MPO ... polyangiitis - MPO
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Thiazide‐like diuretics, MRA ... Pharmacology #Comparison #Table ... #HalfLife #Dosing
ANCA Associated Vasculitis (AAV) - Auto-antibodies and Differential Diagnosis

MPA → usually p-ANCA
GPA → usually c-ANCA
EGPA →
Differential Diagnosis MPA ... usually p-ANCA GPA ... 50% P-ANCA (MPO
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
, Varenicline (tablet ... release (SR) (tablet ... Therapy #Comparison #Table ... #Agents #Dosing
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (GPA ... Polyangiitis (MPA ... #Polyangiitis #GPA ... #Polyangiitis #MPA
Important Blood Pressure Targets in the ED
Subarachnoid Hemorrhage: 
    SBP < 140 -
raised ICP: MAP ... raised ICP: MAP ... : Before TPA ... 24 hours after TPA ... raised ICP: MAP
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Pharmacology #Dosing ... #Dosing #Renal ... Impairment #CKD #Table